651 related articles for article (PubMed ID: 23206666)
1. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction.
Hassan Z; Muzaimi M; Navaratnam V; Yusoff NH; Suhaimi FW; Vadivelu R; Vicknasingam BK; Amato D; von Hörsten S; Ismail NI; Jayabalan N; Hazim AI; Mansor SM; Müller CP
Neurosci Biobehav Rev; 2013 Feb; 37(2):138-51. PubMed ID: 23206666
[TBL] [Abstract][Full Text] [Related]
2. Neurobiology of Kratom and its main alkaloid mitragynine.
Suhaimi FW; Yusoff NH; Hassan R; Mansor SM; Navaratnam V; Müller CP; Hassan Z
Brain Res Bull; 2016 Sep; 126(Pt 1):29-40. PubMed ID: 27018165
[TBL] [Abstract][Full Text] [Related]
3. Kratom policy: The challenge of balancing therapeutic potential with public safety.
Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.
Singh D; Narayanan S; Vicknasingam B; Corazza O; Santacroce R; Roman-Urrestarazu A
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28544011
[TBL] [Abstract][Full Text] [Related]
5. A coincidence of addiction to "Kratom" and severe primary hypothyroidism.
Sheleg SV; Collins GB
J Addict Med; 2011 Dec; 5(4):300-1. PubMed ID: 21817918
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain.
Ramachandram DS; Damodaran T; Zainal H; Murugaiyah V; Ramanathan S
J Basic Clin Physiol Pharmacol; 2019 Oct; 31(1):. PubMed ID: 31665120
[TBL] [Abstract][Full Text] [Related]
7. Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia.
Singh D; Müller CP; Vicknasingam BK; Mansor SM
J Psychoactive Drugs; 2015; 47(2):125-31. PubMed ID: 25950592
[TBL] [Abstract][Full Text] [Related]
8. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
[TBL] [Abstract][Full Text] [Related]
9. Update on the Pharmacology and Legal Status of Kratom.
Prozialeck WC
J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
[TBL] [Abstract][Full Text] [Related]
10. Abuse potential and adverse cognitive effects of mitragynine (kratom).
Yusoff NH; Suhaimi FW; Vadivelu RK; Hassan Z; Rümler A; Rotter A; Amato D; Dringenberg HC; Mansor SM; Navaratnam V; Müller CP
Addict Biol; 2016 Jan; 21(1):98-110. PubMed ID: 25262913
[TBL] [Abstract][Full Text] [Related]
11. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity.
Adkins JE; Boyer EW; McCurdy CR
Curr Top Med Chem; 2011; 11(9):1165-75. PubMed ID: 21050173
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
[TBL] [Abstract][Full Text] [Related]
13. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats.
Carpenter JM; Criddle CA; Craig HK; Ali Z; Zhang Z; Khan IA; Sufka KJ
Fitoterapia; 2016 Mar; 109():87-90. PubMed ID: 26688378
[TBL] [Abstract][Full Text] [Related]
15. Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy.
Harun N; Kamaruzaman NA; Mohamed Sofian Z; Hassan Z
Neurosci Lett; 2022 Mar; 773():136500. PubMed ID: 35114335
[TBL] [Abstract][Full Text] [Related]
16. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
17. Is kratom (
Leong Abdullah MFI; Tan KL; Narayanan S; Yuvashnee N; Chear NJY; Singh D; Grundmann O; Henningfield JE
Clin Toxicol (Phila); 2021 May; 59(5):400-408. PubMed ID: 32870119
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats.
Yusoff NHM; Mansor SM; Müller CP; Hassan Z
Behav Brain Res; 2017 Aug; 332():1-6. PubMed ID: 28559179
[TBL] [Abstract][Full Text] [Related]
19. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
[TBL] [Abstract][Full Text] [Related]
20. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
